Introduction
The etiology of primary biliary cirrhosis (PBC) remains unknown but autoimmune pathogenesis has been suggested (1) . Abnormalities of immunefunction found in PBCinclude hypergammaglobulinemia, serumautoantibodies and circulating immunecomplexesas well as the frequent association with presumed autoimmune disorders (2) . The hypergammaglobulinemia of PBC is caused by polyclonal elevations of serum immunoglobulins, and monoclonal immunoglobulin elevations are rarely found (2) . Onthe other hand, an association of autoimmune disease with malignancy, in particular lymphoproliferative neoplasms, has been reported (3), as has an increased incidence of extrahepatic malignancy in PBC (4, 5) . Wedescribe a patient whohad PBCand multiple myeloma concurrently diagnosed, and discuss the possibility of their causal relation.
Case Report
A 65-year-old man was admitted to Nippon Medical School Hospital on March 10, 1992 for evaluation of renal and liver function disturbances. The patient had been well until 9 months previously, when he passed dark-red urine accompanied by increasing fatigue and low-grade fever over the subsequent three weeks. After a similar episode in the middle of February he visited a nearby hospital, where results of cystoscopic examination were negative. Because biochemical tests of renal and liver function were found to be abnormal, he was referred to our hospital for further evaluation. Liver dysfunction was first pointed out at the age of 59 years, and proteinuria at 61 years.
Onphysical examination, the patient had anemic and icteric conjunctivas. Nocardiac murmursor rales in the lungs were heard. The liver edge was palpable 5 cm beneath the right costal margin. There was no peripheral edema or lymphadenopathy.
The urinalysis was positive for protein but negative for Bence-Jones protein; the sediment contained innumerable red cells and 30 to 35 white cells per high-power field. In a 24-hour specimen of urine, the protein content was 1.6 g. The hematocrit value was 27.3%, hemoglobin 9.2 g/dl, white-cell count 7,100/ mm3with a normal differential count, platelet count 92,000/ mm3, bleeding time >5 min, prothrombin time 85%, activated partial-thromboplastin time 34 sec, and the erythrocyte sedimentation rate 146 mm/h. The blood urea nitrogen level was 81 mg/dl, creatinine 9.3 mg/dl, total bilirubin 2.0 mg/dl and conjugated bilirubin 1.3 mg/dl. Serum aspartate aminotransferase was 40 IU/1, alanine aminotransferase 27 IU/1, lactic dehydrogenase 443 IU/1 (normal: 195 to 365), alkaline phosphatase 939 IU/1 (normal: 65 to 205) and gamma-glutamyl transpeptidase 932 U/l (normal: 4 to 50). Serum electrophoresis disclosed an Mcomponent in the gammaregion and a total protein level of 6.9 g/dl with albumin 3.2 g/dl, alpha2 globulin 0.4 g/dl, alpha2 globulin 0.5 g/dl, beta globulin 0.8 g/dl and gammaglobulin 2.0 g/dl. Immunoelectrophoresis of the serum (Fig. 1 ) showed a broad, dense precipitin arc in the gamma region when anti-IgA antiserum was used. An abnormal arc with a configuration similar to that of the IgA arc also appeared in the same region whenanti-kappa light chain antiserum was used. Quantification of the immunoglobulins revealed the fol- bone marrow smear disclosed marked infiltration by atypical plasma cells (Fig. 2) ; the percentage of plasma cells was 17.6 and the myeloid to erythroid ratio 4.5: 1.0. Most of the plasma cells produced brownish enzyme reaction products when the enzyme-labeled antibody technique with the use of anti-IgA or anti-kappa antibodies was performed. Skeletal roentgenograms showed compression fractures in the bodies of the eleventh and twelfth thoracic and the first lumbar vertebrae, and a diffuse osteoporosis of the spine and pelvis, but no distinct osteolytic lesions or'osteosclerosis.
The free thyroxine level was 0.8 ng/ dl, the free triiodothyronine 0.7 pg/ml, and the thyroid-stimulating hormone 10.8 jiU/ml. A test for anti-mitochondrial antibody was positive in a titer of greater than 1:320. Tests for antinuclear, anti-smooth muscle, anti-microsomal and antithyroglobulin antibodies were negative as well as serological markers for hepatitis B and C viruses. A computed tomography of the abdomenrevealed mild hepatosplenomegaly and ascitic fluid. Upper gastrointestinal endoscopy demonstrated distended esophageal varices. Anappropriate liver biopsy specimen for histological diagnosis could not be obtained with the use of a transjugular approach. Ultrasound-or laparoscopy-guided liver biopsy was not performed because of the presence of ascitic fluid and prolonged bleeding time. The clinical diagnoses were PBC associated with multiple myeloma and primary hypothyroidism. The diagnosis of PBCwas based on raised levels of serum alkaline phosphatase and gamma-glutamyl transpeptidase, a high serum IgM, and a highly positive serum mitochondrial antibody test. Hemodialysis was performed for renal failure, and general measures were taken towards the PBCand myeloma, including control ofpruritus. Systemic chemotherapy of myelomawas not initiated because of the patient' s disagreement. The laboratory data 8 months after the diagnosis were the following: IgA concentration 1 ,53 1 mg/dl, hemoglobin 9.0 g/dl and creatinine 8.9 mg/dl. On January 2, 1993, he died of pneumonia. Autopsy was not permitted.
Discussion
The hypergammaglobulinemia of PBC is of polyclonal variety, and has been attributed to polyclonal B cell activators, defects in hepatic clearance of antigens, or immunologic imbalance between lymphocyte suppressor and helper functions (2) . Benign monoclonal gammopathy is rare in PBC, occurring in 1.8% of cases in one series (2) . However, to ourknowledge, this is the fourth reported case of PBCassociated with multiple myeloma(6-8) ( (1 1) described two patients with alcoholic cirrhosis in whom transformation of polyclonal to monoclonal gammopathywas documented. One of these patients died of overt multiple myeloma. Whether this transformation is a result of chronic antigenic stimulation is unknown (12). 2) PBCand associated myeloma may share a common pathogenesis resulting from abnormal immune function. The cause of PBCis not well understood, but alterations of both cellular and humoral immunefunction have been suggested to play a major role in its pathogenesis (1) . Thus, the two diseases could stem from the altered immunesystem and impaired immunological surveillance, resulting in a hampered ability to suppress and eliminate the emergence and proliferation of neoplastic cells (4, 5) .
